Franklin Biotechnology Discv A(acc)SGD

Performance History31/08/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv A(acc)SGD
Fund102.648.940.5-27.316.5
+/-Cat7.64.8-3.11.6-1.6
+/-Idx-4.44.4-3.7-4.9-0.2
 
Key Stats
NAV
19/09/2017
 SGD 32.50
Day Change -0.19%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0320765992
Fund Size (Mil)
31/08/2017
 USD 2724.39
Share Class Size (Mil)
31/08/2017
 SGD 28.22
Max Initial Charge 5.75%
Ongoing Charge
27/01/2017
  1.83%
Investment Objective: Franklin Biotechnology Discv A(acc)SGD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns19/09/2017
YTD19.03
3 Years Annualised11.65
5 Years Annualised28.84
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
25/10/2007
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A(acc)SGD31/07/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.830.0096.83
Bonds0.000.000.00
Cash2.210.002.21
Other0.960.000.96
Top 5 Regions%
United States97.04
Middle East0.92
United Kingdom0.73
Eurozone0.54
Canada0.43
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.71
Alexion Pharmaceuticals IncHealthcareHealthcare8.32
Incyte CorpHealthcareHealthcare5.98
Regeneron Pharmaceuticals IncHealthcareHealthcare5.35
Biogen IncHealthcareHealthcare4.70
Franklin Biotechnology Discv A(acc)SGD